Pay in 4 interest-free payments of $6.06 Learn more
Ships within 48 hours · Estimated delivery Aug 22 - Aug 27
To our knowledge, no retrospective studies have been conducted to assess the effectiveness of semaglutide at the doses used to treat obesity (ie, 1.7 and 2.4 mg). Researchers conducted a cohort study at a referral center for weight management and included 175 patients (mean age, 49.3 years
Doctors closely monitored the patients internal organs throughout the trial to ensure safety
Reduced desire to drink in patients treated with semaglutide has raised interest regarding its potential therapeutic benefits for alcohol use disorders
Based on large clinical studies and headtohead trials, tirzepatide (Zepbound or Mounjaro) consistently leads to the greatest weight reductions
US$ 21.98
US$ 25.31
US$ 28.28
US$ 22.54
US$ 21.08
US$ 23.86
US$ 27.42
